期刊文献+

磁共振波谱技术诊断肝硬化 被引量:5

Proton magnetic resonance spectroscopy in the diagnosis of hepatic cirrhosis
暂未订购
导出
摘要 目的探讨磁共振1.5T单体素1H-MRS技术在肝硬化中的应用价值,对所得的波谱进行初步分析。方法对20名健康志愿者和20例肝硬化患者行常规MRI和MRS检查,利用Philip公司波谱软件包得出各波峰下面积进行比较。结果所有接受检查者均获得MRS结果。正常组Lip出现率100%,Cho出现率为95.00%,Cr出现率为85.00%,Glx出现率为80.00%,肝硬化组Lip出现率100%,Cho出现率为100%,Cr出现率为70.00%,Lac出现率为75.00%。Glx峰在肝硬化组病例中出现率仅为为20.00%,正常组中无乳酸峰。两组中Lip峰下面积比较差异有统计学意义(P<0.01),而Cho和Cr峰下面积比较差异无统计学意义。结论单体素1H-MRS技术能够分析肝硬化病理改变后的各代谢物质的变化,是无创性检查和评估肝硬化的一种可行方法。 Objective To approach the value of a H-MRS in the diagnosis of the hepatic cirrhosis and to study the changes of the spectrum obtained. Methods Twenty healthy subjects and 20 hepatic cirrhosis subjects underwent conventional MRI and 1^H-MRS of liver. The areas within the spectras were obtained and compared. Results The frequency of Lip, Cho, Cr, and Glx was 100%, 95.00%, 85.00% and 80.00% in healthy subjects, respectively, and the frequency of Lip, Cho, Cr, Lac, and Glx was 100%, 100%, 70. 00%, 75.00% and 20. 00% in hepatic cirrhosis patients, respectively. Lac was absent in healthy subjects. The frequency of Glx in hepatic cirrhosis was much lower than that in healthy subjects. The frequency of Lip between the two groups had significant difference (P〈0. 01), although the frequency of Cho and Cr between the two groups had no significant difference. Conclusion The changes of metabolite in hepatic cirrhosis can be detected and analyzed with 1^H-MRS, which is a feasible, non-invasive technique in the diagnosis of hepatic cirrhosis.
出处 《中国医学影像技术》 CSCD 北大核心 2009年第8期1433-1436,共4页 Chinese Journal of Medical Imaging Technology
基金 陕西省科技攻关项目(2004K12-G10)
关键词 磁共振成像 磁共振波谱 肝硬化 Magnetic resonance imaging Magnetic resonance spectroscopy Hepatic cirrhosis
  • 相关文献

参考文献12

  • 1Burtscher LM, Holtas S. Proton magnetic resonance spectroscopy in brain tumors: clinical applications. Neuroradiology, 2001, 43 (5) :345-352.
  • 2How FA, Opstad KS. ^1H MR spectroscopy of brain tumors and masses. NMR Biomed, 2003,16(3):123-131.
  • 3Li CW, Kuo YC, Chen CY, et al. Quantification of choline compounds inhuman hepatic tumors by proton MR spectroscopy at 3 T. Magn Reson Med, 2005,53(4) :770-777.
  • 4Lim AK, Patel N, Hamilton G, et al. The relationship of in vivo ^31p MR spectroscopy to histology in chronic hepatitis C. Hepatology, 2003,37(4) :788-794.
  • 5颜荣华,肖恩华.兔肝VX2瘤活体二维多体素~1H-MRS成像STEAM和PRESS序列的比较[J].临床放射学杂志,2008,27(2):273-277. 被引量:5
  • 6Cho SG, Kim MY, Kim H J, et aI. Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology, 2001,221 (3) : 740-746.
  • 7Khan SA, Cox IJ, Hamilton G. In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and PMRS applications. Liver Int 2005,25(2) :273-281.
  • 8李玉中,胡宏,陈艳君,许方,李振国,刘越坚.肝病患者血脂变化的临床价值[J].大连医科大学学报,2002,24(4):285-286. 被引量:34
  • 9Towner RA, Foley .LM, Painter DM. Hepatocarcinogenesis tumor grading correlated with in vivo image-guided (1) H-NMR spectroscopy in a rat model. Toxicol Appl Pharmacol, 2005,207(2S):237-244.
  • 10吴坚,叶慧义,孙非,张静,梁燕,马林,蔡幼铨,杨立.肝细胞癌3.0TMR氢质子波谱的初步研究[J].中国医学影像技术,2006,22(12):1856-1859. 被引量:17

二级参考文献46

共引文献56

同被引文献59

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部